Marcin Dragan
Hematology & Oncology · Torrance, CANPI 1508354358
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $806 and has fallen 51.1% since, to $394 in 2024. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.
Across 54 payments — averaging $32.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$251
- AstraZeneca$212
- Bristol Myers Squibb$202
- E.r. Squibb & Sons, L.L.C.$168
- EMD Serono, Inc.$100
- Karyopharm Therapeutics Inc.$88
- plus $719 from 18 others
What the payments were for
- Food & beverage$1,740100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 4 | $251 |
| AstraZeneca | 5 | $212 |
| Bristol Myers Squibb | 7 | $202 |
| E.r. Squibb & Sons, L.L.C. | 4 | $168 |
| EMD Serono, Inc. | 3 | $100 |
| Karyopharm Therapeutics Inc. | 3 | $88 |
| Incyte Corporation | 3 | $80 |
| Blueprint Medicines Corporation | 3 | $70 |
| Sanofi | 3 | $66 |
| Pfizer | 2 | $57 |
| Stemline Therapeutics Inc. | 2 | $55 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Seagen Inc. | 2 | $45 |
| Pharmaessentia USA Corporation | 1 | $34 |
| Gilead | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $30 |
| Eisai Inc. | 1 | $28 |
| The Binding Site Inc. | 1 | $28 |
| Servier Pharmaceuticals LLC | 1 | $25 |
| Rigel Pharmaceuticals, Inc. | 1 | $24 |
| Global Blood Therapeutics, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $23 |
| Mirati Therapeutics, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,740 in reported general payments places this provider in the 40th percentile of 1,363 hematology & oncology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TagrissoOsimertinib Mesylate | 13 | $217,878 |
| Abiraterone Acetate | 16 | $2,390 |
| Hydroxyurea | 21 | $681 |
| Anastrozole | 23 | $627 |
| Dexamethasone | 21 | $251 |
| Ondansetron Hcl | 27 | $227 |
| Prednisone | 21 | $200 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $155 |
| Olanzapine | 12 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTagrisso | $212 | $217,87813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in Torrance
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.